We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Novel Cardiac Implant Provides Life-Saving Treatment for Heart Failure Patients

By HospiMedica International staff writers
Posted on 19 Jun 2024
Print article
Image: The C-MIC device is a novel cardiac implant that redefines heart failure therapy (Photo courtesy of Berlin Heals)
Image: The C-MIC device is a novel cardiac implant that redefines heart failure therapy (Photo courtesy of Berlin Heals)

Heart failure caused by cardiomyopathy is a chronic inflammatory condition where the heart muscle fails to pump sufficient blood to meet the body’s demand for blood and oxygen. It is a progressive disease that becomes increasingly difficult to manage over time. To date, no medical device, drug, or therapy has been able to reverse heart failure, allowing patients to maintain a normal and active lifestyle. Now, a novel cardiac implant aims to provide a breakthrough treatment for patients with heart failure.

The C-MIC (Cardiac Microcurrent Therapy Device) is a small, implantable device developed by Berlin Heals (Zug, Switzerland) that represents a groundbreaking, life-saving treatment option for heart failure. The device utilizes electrical microcurrents to remove excess edema from heart cells through electroosmosis while simultaneously encouraging a transition from reverse remodeling to actual myocardial recovery. It achieves reverse remodeling of cardiac muscle tissue by delivering a constant, low-level direct current (DC), mimicking physiological microcurrents, through two leads/electrodes—one attached to the epicardium of the left ventricle and the other inside the right ventricular cavity. This continuous electrical microcurrent not only reduces inflammation in the heart tissue but also helps expel excess fluid from the heart.

This patented technology is easy to implant and has demonstrated significant clinical improvements in heart failure patients. In a randomized study, 35 C-MIC devices have been successfully implanted, with patients showing rapid enhancements in heart function, heart size, and overall quality of life shortly after receiving the C-MIC. Remarkably, patients' average walking distance in six minutes nearly doubled after four weeks, and their typically enlarged hearts due to dilated cardiomyopathies decreased in size. The electrical microcurrent was imperceptible to the patients and did not affect their heart rhythm. No specific side medication or additional procedures were necessary post-implantation, and the improvements were sustained and even increased over a six-month period. Berlin Heals anticipates CE certification by the end of 2025 or early 2026. Due to its significant benefits for patients, the U.S. Food and Drug Administration (FDA) is particularly supportive of the approval process for the C-MIC implant in the USA.

"We are convinced that we have developed a product for the treatment of severe heart failure that will restore quality of life to many patients worldwide and significantly extend their life expectancy,” said Marko Bagaric, Chief Executive Officer of Berlin Heals Holding AG. “I am convinced that C-MIC will set a new standard in the treatment of these patients in the future. After a short operation, an imperceptible, constant microcurrent flows, which ensures that patients feel very well again within a few weeks."

Related Links:
Berlin Heals

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgical Needle
PORT-JECT

Print article

Channels

Surgical Techniques

view channel
Image: The ExcelsiusFlex and ACTIFY 3D Total Knee System have been granted FDA 510(k) clearance (Photo courtesy of Globus Medical)

New Robotic Navigation Platform Provides Surgeons Best-In-Class Solution for Orthopedic Treatment

Globus Medical (Audubon, PA, USA) has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new robotic navigation platform, ExcelsiusFlex, tailored for total knee arthroplasty... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.